The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Osteoclast-derived activity in the coupling of bone formation to resorption
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
Self-citationTherapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Self-citationManolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,668
Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,503
c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling
Grigoriadis, A. E., Wang, Z.-Q., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., & Wagner, E. F. (1994) · Science · doi:10.1126/science.7939685 · Cited by 1,260
Black, D. M., Greenspan, S. L., Ensrud, K. E., Palermo, L., McGowan, J. A., Lang, T. F., Garnero, P., Bouxsein, M. L., Bilezikian, J. P., & Rosen, C. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031975 · Cited by 1,174
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., & Manolagas, S. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6610 · Cited by 1,043
Role of osteoblasts in hormonal control of bone resorption—A hypothesis
Rodan, G. A., & Martin, T. J. (1981) · Calcified Tissue International · doi:10.1007/bf02409454 · Cited by 982
Self-citationThe Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
Finkelstein, J. S., Hayes, A., Hunzelman, J. L., Wyland, J. J., Lee, H., & Neer, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035725 · Cited by 829
BMP-2 Controls Alkaline Phosphatase Expression and Osteoblast Mineralization by a Wnt Autocrine Loop
Rawadi, G., Vayssière, B., Dunn, F., Baron, R., & Roman-Roman, S. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.10.1842 · Cited by 764
Jiang, Y., Zhao, J. J., Mitlak, B. H., Wang, O., Genant, H. K., & Eriksen, E. F. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.11.1932 · Cited by 616
Dobnig, H. (1995) · Endocrinology · doi:10.1210/en.136.8.3632 · Cited by 615
ERIKSEN, E. F. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-4-379 · Cited by 601
Ma, Y. L., Cain, R. L., Halladay, D. L., Yang, X., Zeng, Q., Miles, R. R., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Endocrinology · doi:10.1210/endo.142.9.8356 · Cited by 428
Self-citationUdagawa, N., Takahashi, N., Yasuda, H., Mizuno, A., Itoh, K., Ueno, Y., Shinki, T., Gillespie, M. T., Martin, T. J., Higashio, K., et al. (2000) · Endocrinology · doi:10.1210/en.141.9.3478 · Cited by 404
Self-citationParfitt, A. M. (1982) · Metabolic Bone Disease and Related Research · doi:10.1016/0221-8747(82)90002-9 · Cited by 399
Wronski, T. J. (1993) · Endocrinology · doi:10.1210/en.132.2.823 · Cited by 290
Decreased C-Src Expression Enhances Osteoblast Differentiation and Bone Formation
Marzia, M., Sims, N. A., Voit, S., Migliaccio, S., Taranta, A., Bernardini, S., Faraggiana, T., Yoneda, T., Mundy, G. R., Boyce, B. F., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.2.311 · Cited by 284
Self-citationSkeletal Renewal and Metabolic Bone Disease
Harris, W. H., & Heaney, R. P. (1969) · New England Journal of Medicine · doi:10.1056/nejm196901232800405 · Cited by 278
Kimble, R. B., Matayoshi, A. B., Vannice, J. L., Kung, V. T., Williams, C., & Pacifici, R. (1995) · Endocrinology · doi:10.1210/endo.136.7.7789332 · Cited by 273
Howard, G. A., Bottemiller, B. L., Turner, R. T., Rader, J. I., & Baylink, D. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3204 · Cited by 266
Frost, H. M. (1964) · Medical Entomology and Zoology · Cited by 232
Weitzmann, M. N., Roggia, C., Toraldo, G., Weitzmann, L., & Pacifici, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15687 · Cited by 223
Transforming growth factor-beta and remodeling of bone.
Centrella, M., McCarthy, T. L., & Canalis, E. (1991) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199173090-00022 · Cited by 214
Frolik, C. A., Black, E. C., Cain, R. L., Satterwhite, J. H., Brown-Augsburger, P. L., Sato, M., & Hock, J. M. (2003) · Bone · doi:10.1016/s8756-3282(03)00202-3 · Cited by 211
Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene
Hoff, A. O., Catala-Lehnen, P., Thomas, P. M., Priemel, M., Rueger, J. M., Nasonkin, I., Bradley, A., Hughes, M. R., Ordonez, N., Cote, G. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214218 · Cited by 209
Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo
Dacquin, R., Davey, R. A., Laplace, C., Levasseur, R., Morris, H. A., Goldring, S. R., Gebre-Medhin, S., Galson, D. L., Zajac, J. D., & Karsenty, G. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312135 · Cited by 206
Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways
Sims, N. A., Jenkins, B. J., Quinn, J. M. W., Nakamura, A., Glatt, M., Gillespie, M. T., Ernst, M., & Martin, T. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19872 · Cited by 194
Self-citationOsteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.
Nakamura, M., Udagawa, N., Matsuura, S., Mogi, M., Nakamura, H., Horiuchi, H., Saito, N., Hiraoka, B. Y., Kobayashi, Y., Takaoka, K., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0717 · Cited by 191
Delmas, P. D., Vergnaud, P., Arlot, M. E., Pastoureau, P., Meunier, P. J., & Nilssen, M. H. L. (1995) · Bone · doi:10.1016/8756-3282(95)00113-r · Cited by 171
Black, D. M., Greenspan, S. L., Ensrud, K. E., Palermo, L., McGowan, J. A., Lang, T. F., Garnero, P., Bouxsein, M. L., Bilezikian, J. P., & Rosen, C. J. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000115856.54444.d6 · Cited by 159
Onyia, J. E., Bidwell, J. P., Herring, J., Hulman, J. F., & Hock, J. M. (1995) · Bone · doi:10.1016/8756-3282(95)00332-2 · Cited by 157
Schaller, S., Henriksen, K., Sveigaard, C., Heegaard, A., Hélix, N., Stahlhut, M., Ovejero, M. D. C., Johansen, J. V., Solberg, H., Andersen, T. L., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040302 · Cited by 153
Xing, L., Venegas, A. M., Chen, A. Y.-C., Garrett-Beal, L. J., Boyce, B. F., VARMUS, H. E., & Schwartzberg, P. L. (2001) · Genes & Development · doi:10.1101/gad.840301 · Cited by 111
Topographically induced bone formation in vitro: Implications for bone implants and bone grafts
Gray, C., BOYDE, A., & Jones, S. J. (1996) · Bone · doi:10.1016/8756-3282(95)00456-4 · Cited by 110
Anabolic Actions of Parathyroid Hormone during Bone Growth Are Dependent on c-fos
Demiralp, B., Chen, H.-L., Koh, A. J., Keller, E. T., & McCauley, L. K. (2002) · Endocrinology · doi:10.1210/en.2002-220221 · Cited by 110
Interleukins in the Control of Osteoclast Differentiation
Martin, T. J., Romas, E., & Gillespie, M. T. (1998) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v8.i2.10 · Cited by 109
Self-citationStructural and geometric changes in iliac bone: Relationship to normal aging and osteoporosis
Földes, J., PARFITT, A. M., Shih, M. S., Rao, D. S., & Kleerekoper, M. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060714 · Cited by 108
Holtrop, M. E., King, G. J., Cox, K. A., & Reit, B. (1979) · Calcified Tissue International · doi:10.1007/bf02441175 · Cited by 101
Parathyroid Hormone plus Alendronate — A Combination That Does Not Add Up
Khosla, S. (2003) · New England Journal of Medicine · doi:10.1056/nejme038143 · Cited by 75
Stanislaus, D., Yang, X., Liang, J., Wolfe, J. M. T., Cain, R. L., Onyia, J. E., Falla, N., Marder, P., Bidwell, J. P., Queener, S. W., et al. (2000) · Bone · doi:10.1016/s8756-3282(00)00309-4 · Cited by 72
Day, C. J., Kim, M. S., Stephens, S., Simcock, W. E., Aitken, C. J., Nicholson, G. C., & Morrison, N. A. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10780 · Cited by 66
Coupling of Bone Resorption and Formation during Bone Remodeling
Martin, T. J., & Rodan, G. A. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50013-1 · Cited by 65
Self-citationBaron, R., Chakraborty, M., Chatterjee, D., Horne, W. C., Lomri, A., & Ravesloot, J. H. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-77991-6_3 · Cited by 47
Does bone resorption inhibition affect the anabolic response to parathyroid hormone?
Martin, T. J. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.01.002 · Cited by 38
Self-citationOsteoclasts Secrete the Chemotactic Cytokine Mim-1
Falany, M. L., Thames, A. M., McDonald, J. M., Blair, H. C., McKenna, M. A., Moore, R. E., Young, M. K., & Williams, J. P. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4307 · Cited by 35
Hormonal Factors Which Regulate Bone Resorption
Mundy, G. R. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-77991-6_6 · Cited by 9
Reduced Bone Formation in the Pathogenesis of Bone Fragility
Martin, T. J., & Seeman, E. (2004) · Springer eBooks · doi:10.1007/978-1-4471-3777-1_6 · Cited by 2
Self-citation
Cited by
Normal Bone Anatomy and Physiology
Clarke, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04151206 · Cited by 2,192
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Inflammatory and immune pathways in the pathogenesis of periodontal disease
Cekici, A., Kantarci, A., Hasturk, H., & Van Dyke, T. E. (2014) · Periodontology 2000 · doi:10.1111/prd.12002 · Cited by 1,415
“Before the discovery of RANK, its ligand (RANKL) and its antagonist (osteoprotegerin), the development and the formation of osteoclasts were thought to be controlled by factors produced by osteoblasts and bone marrow stromal cells (162, 198).”
BackgroundCellular and molecular mechanisms of bone remodeling
Raggatt, L. J., & Partridge, N. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.041087 · Cited by 1,402
Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts
Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.025 · Cited by 1,013
Self-citation
Metadata
- Authors
- Martin, T. J., & Sims, N. A.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 11
- Issue
- 2
- Pages
- 76-81
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2022112190
- Cited by
- 659
- References
- 50
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.